Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

BMY - Bristol-Myers Squibb Co.

Close
49.95
0.230   0.460%

Share volume: 9,590,861
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$49.72
0.23
0.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 23%
Dept financing 48%
Liquidity 71%
Performance 49%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.82%
1 Month
1.83%
3 Months
25.99%
6 Months
0.75%
1 Year
-15.96%
2 Year
-19.41%
Key data
Stock price
$49.95
P/E Ratio 
-15.48
DAY RANGE
$49.68 - $50.24
EPS 
-$3.21
52 WEEK RANGE
$39.04 - $59.08
52 WEEK CHANGE
-$0.15
MARKET CAP 
101.268 B
YIELD 
4.65%
SHARES OUTSTANDING 
2.027 B
DIVIDEND
$0.60
EX-DIVIDEND DATE
07/05/2024
NEXT EARNINGS DATE
10/31/2024
BETA 
0.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,953,408
AVERAGE 30 VOLUME 
$11,734,460
Company detail
CEO: Giovanni Caforio
Region: US
Website: https://www.bms.com/
Employees: 34,300
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Recent news